 CAMBRIDGE, Mass., Jan. 05, 2021 GLOBE NEWSWIRE -- Agios Pharmaceuticals, Inc. NASDAQ:AGIO, a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced that the company is scheduled to present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. ET. 